ArthroCare® Receives FDA Clearance for SpeedLock® Knotless Fixation Device

AUSTIN, Texas--(BUSINESS WIRE)--ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its SpeedLock® Knotless Fixation Device (SpeedLock). SpeedLock, a push-in implant made of PEEK (polyether-etherketone) polymer, provides surgeons with independent bone lock, suture tensioning and suture lock and is indicated for soft tissue fixation to bone, primarily in labral repair procedures. SpeedLock is expected to complement ArthroCare’s broad line of suture anchors and ArthroCare’s suture passing technology, including the SpeedStitch® suturing device.